Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family.
We analysed the clinical and analytical features of 18 subjects from a Spanish family who bear several combinations of two prothrombotic mutations, factor V Leiden (FVL) and prothrombin 20210A. We identified three subjects homozygous for the 20210A prothrombin mutation which additionally were heterozygous for FVL. The combination of both mutations increases the risk of developing venous thrombotic episodes at the earlier age. However, even in association with FVL, the homozygous condition of the prothrombin 20210A mutation requires additional risk factors to induce a thrombotic event. Finally, the plasma level of factor II showed a significant relationship with the prothrombin genotype.
Corral
J
J
Unidad de Hematología y Oncología Clínica, Hospital General Universitario, Murcia, Spain.
Zuazu-Jausoro
I
I
Rivera
J
J
González-Conejero
R
R
Ferrer
F
F
Vicente
V
V
D000328:Adult; D000368:Aged; D005165:Factor V / Q000235:genetics*; D005260:Female; D006720:Homozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D011516:Prothrombin / Q000235:genetics*; D013030:Spain; D020246:Venous Thrombosis / Q000235:genetics*
C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin